| Name | Title | Contact Details |
|---|
We are a thriving community bank that prides ourselves on hard work, friendly and knowledgeable customer service, and convenient, local banking. Since November of 2000, BCB has been offering a wide range of loans, deposit products, and retail and commercial banking services. As of today, there are twenty-seven branches expanding across the NJ & NY areas and one administrative office located in Bayonne, NJ. BCB continues to find ways of improving our services for an enjoyable and hassle-free banking experience seven days a week. We are a member of the FDIC and an Equal Housing Lender.
Polestar Solutions & Services is a global AI and analytics company focused on enterprise transformation through data-driven solutions. Founded by experienced technocrats, the company operates in the U.S. and India, with offices in cities like Dallas, Noida, and Mumbai. With over 600 employees, Polestar is projected to grow by 60% globally in the coming year. The company specializes in AI-powered analytics, serving industries such as consumer packaged goods, retail, manufacturing, and pharmaceuticals. Polestar offers a range of services, including generative AI, data engineering, and advanced analytics platforms. It develops tailored solutions for revenue growth management, supply chain optimization, and customer analytics. Polestar is recognized as a Great Place to Work and has received multiple awards for its growth and excellence in AI and analytics services. Its mission is to empower businesses through intelligent, data-driven transformation.
TICA group middle east is the branch and after-sale service center of TICA Air condition in the middle east, TICA is one of the leading manufacturers of HVAC (Heating, Ventilation and Air Conditioning) equipment in the world. #HVAC #VRF #CHILLER #DX
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.